The treatment of chronic hepatitis B

Principle of treatment of chronic hepatitis B can be broadly grouped into the following points:

(1) reasonable rest, reasonable nutrition, good mentality is to rehabilitate an important factor in the disease: For patients with chronic hepatitis can not stress the absolute bed rest, can be taken to the activities of combining static and dynamic manner, fluctuations in the condition is not large, For example, no jaundice, you can engage in a general household chores, you can walk, but not to do a very intense physical activity. Face reality, the correct treatment of the disease, is an important prerequisite for the swift return of health.

(2) suitable, appropriate anti-viral therapy: the so-called suitable, appropriate anti-viral therapy is: ① viral replication in patients with clear indicators, here to point out that, HBV-DNA positive by dot-blot hybridization to be positive as the Instead, they can not be confined to polymerase chain reaction-positive as an indicator; ② Select the timing of antiretroviral therapy should be appropriate for patients with the disease should choose the most active period in the inflammation, ALT should be higher than the obvious inference in liver biopsy in chronic hepatitis light-or medium-sized, so it easy to achieve a higher efficacy; ③ types of antiviral drugs of choice for patients with appropriate doses of appropriate course of treatment suitable for; ④ close observation, to avoid the toxic side effects of antiviral drugs occur; ⑤ If it is combined medication, Drug mix should be reasonable; ⑥ treatment of choice should be the patient's economic means to tolerance.

(3) carefully selected patients with 12 kinds of convenient, easy to get the immune enhancer, the choice of drugs may be a result of land vary. Species should not be too much.

(4) With regard to the choice of drugs should be followed in simple not complex, should not refined the principles of chaos. A total of not more than five kinds of drugs available from the anti-virus, immune regulation, anti-fibrosis, to improve the symptoms of 34 aspects. According to different conditions, different stage of disease, different ages, different symptoms vary.

(5) In considering the various joint drug program, should pay attention to the different roles of the joint mechanism of drugs such as interferon plus thymosin, interferon plus Zadaxin, interleukin -2 plus interferon, interleukin -2 gala lamivudine and so on, do not select the same mechanism of action of the drug re-union, such as acyclovir plus lamivudine.

(6) should increase the incentive to avoid the disease, such as fatigue, upper respiratory infection, diarrhea, emotional volatility, to liver damage drug applications.

(7) regular follow-up, track time due to people, and the illness to another. Follow-up, in addition to check the liver function, it is important to dynamically track the changes in B-ultrasound to observe the size of the liver, with or without thickening of the spleen, portal and splenic vein widened and so on.